Loss of heterozygosity at 3p14.2 (FHIT locus) and loss of FHIT protein expression are frequent events in conventional (clear cell) renal carcinoma

被引：0
|
作者：
Moch, H [1 ]
Hutz, F [1 ]
Schraml, P [1 ]
Bednar, R [1 ]
Struckmann, K [1 ]
Sauter, G [1 ]
Mihatsch, MJ [1 ]
机构：
[1] Univ Basel, Inst Pathol, Basel, Switzerland
来源：
LABORATORY INVESTIGATION | 2001年 / 81卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
681
引用
收藏
页码：117A / 117A
页数：1
相关论文
共 50 条
  • [1] Loss of heterozygosity at 3p14.2 (FHIT locus) and loss of FHIT protein expression are frequent events in conventional (clear cell) renal carcinoma
    Moch, H
    Hatz, F
    Schraml, P
    Bednar, R
    Struckmann, K
    Sauter, G
    Mihatsch, MJ
    MODERN PATHOLOGY, 2001, 14 (01) : 117A - 117A
  • [2] Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus
    Velickovic, M
    Delahunt, B
    Grebe, SKG
    CANCER RESEARCH, 1999, 59 (06) : 1323 - 1326
  • [3] Loss of heterozygosity (LOH) at 3p14.2 (FHIT) in infiltrating ductal carcinoma of the breast.
    Lozano, MD
    Sola, I
    Toledo, G
    Soria, E
    de Alava, E
    Pardo, FJ
    LABORATORY INVESTIGATION, 2001, 81 (01) : 31A - 31A
  • [4] Loss of heterozygosity (LOH) at 3p14.2 (FHIT) in infiltrating ductal carcinoma of the breast.
    Lozano, MD
    Sola, I
    Toledo, G
    de Alava, E
    Pardo, FJ
    MODERN PATHOLOGY, 2001, 14 (01) : 31A - 31A
  • [5] Loss of FHIT expression in gastric adenocarcinomas: Correlation with loss of heterozygosity (LOH) AT 3p14.2 and other molecular and clinical features
    Sola, I
    Tejada, S
    Idoate, M
    Lozano, MD
    Pardo, FJ
    MODERN PATHOLOGY, 2001, 14 (01) : 95A - 95A
  • [6] Loss of FHIT expression in gastric adenocarcinomas: Correlation with loss of heterozygosity (LOH) at 3p14.2 and other molecular and clinical features.
    Sola, I
    Tejada, S
    Idoate, M
    Lozano, MD
    Pardo, FJ
    LABORATORY INVESTIGATION, 2001, 81 (01) : 95A - 95A
  • [7] Loss of FHIT expression in non-small-cell lung carcinomas: Correlation with loss of heterozygosity (LOH) at 3p14.2 and other molecular and clinical features.
    Toledo, G
    Sola, I
    Lozano, MD
    Soria, E
    Torre, W
    Pardo, FJ
    MODERN PATHOLOGY, 2001, 14 (01) : 227A - 227A
  • [8] Loss of FHIT expression in non-small-cell lung carcinomas: Correlation with loss of heterozygosity (LOH) at 3p14.2 and other molecular and clinical features.
    Toledo, G
    Sola, I
    Lozano, MD
    Soria, E
    Torre, W
    Pardo, FJ
    LABORATORY INVESTIGATION, 2001, 81 (01) : 227A - 227A
  • [9] Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines
    Simon, B
    Bartsch, D
    Barth, P
    Prasnikar, N
    Münch, K
    Blum, A
    Arnold, R
    Göke, B
    CANCER RESEARCH, 1998, 58 (08) : 1583 - 1587
  • [10] The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors
    Frank, S
    Muller, J
    Plaschke, J
    Hahn, M
    Hampl, J
    Hampl, M
    Pistorius, S
    Schackert, G
    Schackert, HK
    CANCER RESEARCH, 1997, 57 (13) : 2638 - 2641
12345